Merck & Company to transform drug developments with Smart Inventory Management and Customer Intelligence

Key Insights and Signals – Hospital & Healthcare

Centre Setup and Expansion
AdventHealth opens a new clinic for long-haul COVID treatment
The new clinic will help people who still have COVID-19 symptoms three months after the virus left their bodies. Dr. Dwyane Gordon oversees this new clinic. Read More>>
Willis-Knighton opens WK Northwood Medical Plaza in Blanchard
The medical plaza is the latest in a new healthcare model by Willis-Knighton that combines WK Quick Care with WK Physician Network clinics and diagnostic X-ray services. Read More>>
Guardant Health lays off 130 employees, or 7 percent of its workforce
Departments including Account management, Bioinformatics, and Technology Development were affected by the layoffs and restructuring. Read More>>
Merger and Acquisition
AlerisLife Chairman to buy company via ABP Acquisition for USD 43.8 Mn
ABP would pay USD 1.31 per share to acquire AlerisLife, marking an 85% premium to the average trading price over the past 30 trading days. Read More>>
Agilent and Quest Diagnostics to collaborate on Lung Cancer Diagnostics
The two companies inked the deal to expand access to the Agilent Resolution ctDx FIRST liquid biopsy sequencing test. The ctDx FIRST is targeted at non-small lung cancer patients. Read More>>
Executive Movements
PacificSource Health Plans names President and CEO
Dr. John Espinola will replace retiring Ken Provencher on April 3. Espinola comes from Blue Cross, where he served as Executive VP and Chief Strategy and Product Officer. Read More>>
Bryan T. Kelly to succeed Shapiro as CEO of Hospital for Special Surgery
Kelly will succeed President and CEO Louis A. Shapiro in a phased-in handover in 2023. Kelly joined HSS in 1996 and is a world-renowned surgeon, scientist, and educator specializing in sports medicine. Read More>>
St. Jude Children’s names first Chief Business Innovation Officer
In this new role, Ms. Corbin will manage the Office of Strategic Innovation and Design, allocating its USD 3 Bn to construction projects. Ms. Corbin has served as Partner & Director at IDEO’s Chicago Studio. Read More>>
Financial and Market Activity
Parkview Health reports net losses ahead of UCHealth merger
The Health system has agreed to merge with UCHealth and reported a net operating loss of USD 11.2 Mn for six months. Investment values gave a boost in the most recent six-month period to help mitigate overall losses. Read More>>
Dr Lal PathLabs Q3 Results: Net profit drops 8% to USD 6.5 Mn
Revenues declined 1.5% to USD 59 Mn in Q3FY23 from USD 60.8 Mn in Q3FY2022. Non-Covid revenues climbed 9.1% to USD 57 Mn, while Covid testing revenues fell 80.4% to USD 1.3 Mn. Read More>>

Key Insights and Signals in Medical Devices

Product Launch
Axion Biosystems launched a new live-cell imaging platform, Omni Pro 12
The platform features integrated robotics and a multi-plate design compatible with any incubator. It offers enhanced flexibility to scientists and drug developers conducting live-cell imaging experiments. Read More>>
Bio-Techne releases new RNAscope Plus smRNA-RNA Detection Assay
The device allows single-cell and sub-cellular fluorescence detection of a small regulatory RNA with chosen RNAs or biomarkers in the same tissue area. Read More>>
Qiagen Digital Insights launches NGS analysis to process whole genome
The upgraded product processes the whole genome in 25 minutes for $1 in cloud computing costs. Qiagen CLC Genomics Workbench Premium software speeds up the whole genome, whole exome, and large panel sequencing data processing and interpretation. Read More>>
Manipal Hospitals ties up with Fujifilm for storing sensitive medical documents
Under the long-term agreement, the hospital would be provided with a large-scale Picture Archiving and Communication System (PACS) powered by FUJIFILM India. Read More>>
European Radiosurgery Center Munich invests in second Accuray CyberKnife System
The next-gen CyberKnife S7 System will enable their team to treat the high volume of patients who would benefit from extremely precise radiation treatments. Read More>>
Executive Movement
ResMed appoints Michael Farrell as Chair of its Board
The company’s board of directors has appointed CEO Michael Farrell as chair of the board. Mr. Farrell succeeds the current chair Peter Farrell who will become chair emeritus and remain an active board member. Read More>>
Financial and Market Activity
Bio-Techne Fiscal Q2 Revenues Inch up as Protein business lags but Genomics boom
In Q2, the firm reported Diagnostics and Genomics revenues of USD 68 Mn, up 5 percent YoY from USD 64.5 Mn. The company reported USD 203.9 Mn in revenues for the Protein Business, down 1 percent from USD 205.0 Mn in the prior-year quarter. Read More>>
Siemens Healthineers Q1 Dx revenues fall 21 Percent
The company’s diagnostics revenues fell 21 percent in the first fiscal quarter on softer demand for rapid COVID-19 antigen tests, although its overall revenues remained flat year to year. Read More>>

Key Insights and Signals in Pharmaceutical

AstraZeneca, Capitainer to develop biomarker protocols using at-home patient sampling device
The research collaboration with AstraZeneca R&D aims to develop protocols for biomarkers relevant to AstraZeneca’s clinical drug programs using Capitainer’s self-sampling product. Read More>>
Mass Hiring
Moderna to add approximately 2,000 jobs in Greater Boston
The company employs over 3,900 people globally. The company plans to add over 2,000 new regional employees this year. Read More>>
Executive Movement
CureVac Welcomes Myriam Mendila as New Chief Development Officer
Myriam’s expertise in product development in the pharmaceutical industry, particularly in oncology, will be a significant asset to CureVac to advance their mRNA product pipeline. Read More>>
Product Launch
Hikma launched naloxone hydrochloride injection
The drug is used for the emergency treatment of a known or suspected opioid overdose and is the third PFS product launched by Hikma. The launch of this product expands Hikma’s portfolio of addiction therapy treatments. Read More>>
Financial and Market Activity
Alembic Pharma Q3 PAT slips 29% YoY
The company reported a 29% drop in consolidated net profit to USD 14.6 Mn despite an 18.7% rise in net sales to USD 180 Mn in Q3 FY23 over Q3 FY22. PBT declined 23.05% YoY to USD 18 Mn in the quarter ended 31 December 2022. Read More>>
Bulgaria’s Sopharma grows non-cons net profit by 66% in 2022
The company’s standalone net profit soared to USD 21 Mn in 2022 from USD 13 Mn the year prior. Exports to European countries grew by an annual 16.3% to USD 64 Mn as sales in Russia and Ukraine increased, by 11% and 20%, respectively. Read More>>
Laurus Labs posts a 32% profit jump on demand for drug ingredients
The company reported a 32.1% rise in third-quarter profit supported by strong demand for chemicals and other ingredients used in medicines. Read More>>
Did you find the newsletter helpful? *|SURVEY: Yes|* *|SURVEY: No|*

Latest Industry Insights from Draup Braindesk

Medical Devices:
  1. Abbott Laboratories wants to develop a neuromodulation device that wirelessly charges and has the lowest recharge load compared to competing rechargeable SCS systems. 
  2. Abbott Laboratories improves chronic pain patient charging and develops SCS therapy to enable future advancements without changing the implant. 
  3. Abbott Laboratories’ Talisman system, based on the Amplatzer PFO Occluder, simplifies physician usage and reduces preparation time. 
  4. Abbott Laboratories is developing a new aspiration system to break up and remove peripheral vascular clots.
Nutritional Products:
  1. Abbott Laboratories’ AI-enabled nutritional mobile app helps diabetic patients follow their doctors’ advice on food, medication, and other health concerns. 
  2. Abbott Laboratories strives to use a 3D Printing platform to develop prototype tools that enhance nutritional product development for devices used to treat vascular disease. 
  3. Abbott Laboratories wants to create FreeStyle Libre sensor-based technology to illustrate the effect of dietary choices on health.
Service Opportunities:
  1. Greater Chicago Area, United States, serves as the hub focusing on System Integration, Business Intelligence & Analytics, and IT Consulting related engagements. 
  2. Product Engineering Services is the highly outsourced segment and holds approximately 36% of the total outsourcing headcount. IBM and Cognizant are the key strategic partners for Abbott Laboratories.

Key Funding Alert

VitaDAO raises USD 4.1 Mn featuring Pfizer 
VitaDAO’s first biotech firm, whose announcement is expected in March 2023, will be built using part of this funding. This will be the first such involvement by a DAO in the science research and medical fields. Read More>>

Startup Spotlight

Company – Enable Dental
Total Funding USD 16.34 Mn
About: Enable Dental’s mission is to expand access to dental care for in-need populations. The company leverages technology to tailor patient experiences, improve results, and minimize delivery costs. Read More>>

Latest Reports Published in Draup

Merck & Company Account Intelligence Report
Merck focuses on developing their supply chain, drug developments, and manufacturing operations through smart inventory management and customer intelligence. Read More>>
Here’s what’s new on our Sales Intelligence Platform
Introducing Account Priorities View in Business Intentions
Identify account priorities quickly with the refreshed new view of Business Intentions.
View All Updates
Copyright © *|CURRENT_YEAR|* Draup, All rights reserved.

We are located at: *|HTML:LIST_ADDRESS_HTML|* *|END:IF|*

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.